Olympian Caster Semenya cleared to compete as a woman without taking testosterone-reducing drugs

Caster Semenya
Image: AAP/Darren England

Runner Caster Semenya will be allowed to compete without having to take testosterone-reducing medication after a Swiss court ordered the International Association of Athletics Federations to suspend implementation of new regulations while Semenya’s appeal is pending.

The court ruled that the two-time Olympic 800-meter champion, the dominant force in women’s middle distance running, is clear to race in events of all distances, according to a news release.

Semenya reacted with a Tweet saying “Born a winner,” and an image with the quote: “Be the change that you wish to see in the world.”

Last month the IAAF — athletics’ governing body — adopted a controversial policy which required athletes with a difference in sex development (DSD) to take medication to reduce their blood testosterone levels, if they wanted to compete internationally at middle-distance events.

“I am thankful to the Swiss judges for this decision,” Semenya, who is hyperandrogenous — meaning she has elevated levels of testosterone — said in a statement.

…

Athletics’ governing body believes DSD athletes have a competitive advantage — findings that were disputed by Semenya and her legal team.

Read full, original post: Caster Semenya: Olympic champion cleared to compete

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
newborn baby spit up gerd
Vaccine-preventable congenital infections are a leading driver of autism
Screenshot-2026-10-14-at-11.45.36-AM
Viewpoint: RFK Jr.’s stacked FDA advisory council endorses multicancer screening test from ethically- questionable company that would increase false positives and waste billions of dollars
Misinformation-Shatters-the-Clockwork-Mind
Viewpoint: The price Americans pay for science denialism
Screenshot-2026-10-15-at-12.13.33-PM
Ahead of the midterms, Meta has paid at least 29 anti-LGBTQ accounts for their posts
Screenshot-2026-10-14-at-12.47.21-PM
Viewpoint: Are these Trump-conservative GOP doctor-politicians violating their medical oath?
Screenshot-2026-10-08-at-10.41.33-AM
Viewpoint: Wellness patches: Most vitamin supplements are useless and sometimes even dangerous, but this craze is even worse
Crossed-Out-Calendar-with-Milk-Carton
Viewpoint: The shocking consequences after a year of Robert F. Kennedy Jr.'s distortions, deceptions, and flat-out falsehoods
Pride and Patriotism in the Breeze
Retreat from identity labels: Does the sharply declining number of young teens identifying as gay and bisexual reflect an ideological shift?
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
Screenshot-2026-10-07-at-1.03.15-PM
Anti-vaxxers’ double whammy: Exaggerated vaccine fears have fueled measles outbreaks and preventable deaths—and left survivors more vulnerable to other infections for years
Cross and Syringe Standoff
Viewpoint: Hijacking Jesus: How anti-vaccine fanatics are exploiting religious exemptions and killing children
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.